Sun Pharma's arm launches CEQUA for Canadians living with dry eye disease

27 Jan 2022 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Canada Inc has launched CEQUA, a new treatment for Canadians living with dry eye disease. CEQUA (cyclosporine ophthalmic solution 0.09% w/v), a calcineurin inhibitor immunomodulator, is the first dry eye treatment available in Canada that is delivered with nanomicellar (NCELL) technology, which improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration.

This launch is an important milestone for Sun Pharma as company expand its ophthalmics portfolio into Canada and it demonstrates its commitment to providing innovative medicines to support patient and physician choice.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1635.00 3.35 (0.21%)
27-Jan-2026 12:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.00
Dr. Reddys Lab 1242.60
Cipla 1308.45
Zydus Lifesciences 891.95
Lupin 2143.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×